You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 6, June 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risk Factors for Choroidal Neovascularization in the Second Eye of Patients With Juxtafoveal or Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Macular Photocoagulation Study Group

Arch Ophthalmol. 1997;115(6):741-747.


Abstract

Objectives
To verify and quantify previously reported risk factors for development of choroidal neovascularization (CNV) in the fellow eye of patients with 1 eye affected with CNV secondary to age-related macular degeneration, to examine the value of characteristics of the pericentral macula in the quantification of risk for developing CNV, and to explore whether the presence of occult CNV in the first eye affects the development of CNV in the fellow eye.

Design, Patients, and Setting
Follow-up study of fellow eyes of 670 patients enrolled in multicenter, randomized clinical trials of laser photocoagulation of juxtafoveal or subfoveal CNV.

Main Outcome Measure
Development of CNV.

Results
Three characteristics of the central macula of the fellow eye and 1 systemic factor were associated independently with an increased risk of developing CNV: the presence of 5 or more drusen (relative risk, 2.1; 95% confidence interval,1.3-3.5), focal hyperpigmentation (relative risk, 2.0; 95% confidence interval, 1.4-2.9), 1 or more large drusen (relative risk, 1.5; 95% condfidence interval 1.0-2.2), and definite systemic hypertension (relative risk, 1.7; 95% confidence interval, 1.2-2.4). Estimated 5-year incidence rates ranged from 7% for the subgroup with no risk factors to 87% for the subgroup with all 4 risk factors. Characteristics of the pericentral macula were not strongly associated with the development of CNV. The presence of occult CNV in the first eye affected had no influence on the development of CNV or on the type of CNV in the fellow eye.

Conclusions
The prognosis of the fellow eye is affected strongly by characteristics of its central macula and by systemic hypertension. These factors should be considered when counseling patients with unilateral neovascular age-related macular degeneration and when targeting patients for preventive interventions.



Author Affiliations

Prepared for the Macular Photocoagulation Study (MPS) Group by Maureen G. Maguire, PhD; Susan B. Bressler, MD; Neil M. Bressler, MD; Judith Alexander; Cheryl J. Hiner; Noreen B. Javornik, MS; Deborah Phillips; Marta J. Marsh, MS; Barbara S. Hawkins, PhD; Dean B. Burgess, MD; Suresh Chandra, MD; Michael L. Klein, MD; David H. Orth, MD; Thomas Stevens, MD; and Stuart L. Fine, MD. A complete list of the members of the MPS Group as of December 31, 1993, was published previously (Archives of Ophthalmology 1996;114:400-412). No member of the MPS Group has any proprietary interest in the development or marketing of any commercially available products used by these studies.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Description of the Age-Related Eye Disease Study 9-Step Severity Scale Applied to Participants in the Complications of Age-related Macular Degeneration Prevention Trial
Ying et al.
Arch Ophthalmol 2009;127:1147-1151.
ABSTRACT | FULL TEXT  

A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration
Karnon et al.
Med Decis Making 2009;29:304-316.
ABSTRACT  

Age-Related Macular Degeneration
Jager et al.
NEJM 2008;358:2606-2617.
FULL TEXT  

Age-related macular degeneration: diagnosis and management
Cook et al.
Br Med Bull 2008;85:127-149.
ABSTRACT | FULL TEXT  

Racial Differences in the Prevalence of Age-Related Macular Degeneration: The Salisbury Eye Evaluation (SEE) Project
Bressler et al.
Arch Ophthalmol 2008;126:241-245.
ABSTRACT | FULL TEXT  

Incident Choroidal Neovascularization in Fellow Eyes of Patients With Unilateral Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: SST Report No. 20 From the Submacular Surgery Trials Research Group
Submacular Surgery Trials Research Group
Arch Ophthalmol 2007;125:1323-1330.
ABSTRACT | FULL TEXT  

Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice
Koto et al.
IOVS 2007;48:4328-4334.
ABSTRACT | FULL TEXT  

Interleukin-6 Receptor-Mediated Activation of Signal Transducer and Activator of Transcription-3 (STAT3) Promotes Choroidal Neovascularization
Izumi-Nagai et al.
Am. J. Pathol. 2007;170:2149-2158.
ABSTRACT | FULL TEXT  

Age-related macular degeneration and recent developments: new hope for old eyes?
Morris et al.
Postgrad. Med. J. 2007;83:301-307.
ABSTRACT | FULL TEXT  

Cigarette Smoking, CFH, APOE, ELOVL4, and Risk of Neovascular Age-Related Macular Degeneration
DeAngelis et al.
Arch Ophthalmol 2007;125:49-54.
ABSTRACT | FULL TEXT  

Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model.
Korobelnik et al.
IOVS 2006;47:4270-4276.
ABSTRACT | FULL TEXT  

A 76-year-old man with macular degeneration.
Arroyo
JAMA 2006;295:2394-2406.
FULL TEXT  

Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration.
Metelitsina et al.
Br J Ophthalmol 2006;90:342-346.
ABSTRACT | FULL TEXT  

Drusen complement components C3a and C5a promote choroidal neovascularization
Nozaki et al.
Proc. Natl. Acad. Sci. USA 2006;103:2328-2333.
ABSTRACT | FULL TEXT  

Hypertensive retinopathy revisited: some answers, more questions
Grosso et al.
Br J Ophthalmol 2005;89:1646-1654.
ABSTRACT | FULL TEXT  

The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 17
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1484-1498.
ABSTRACT | FULL TEXT  

A Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 18
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1570-1574.
ABSTRACT | FULL TEXT  

Prevalence of Age-Related Macular Degeneration in a Population-Based Sample of Hispanic People in Arizona: Proyecto VER
Munoz et al.
Arch Ophthalmol 2005;123:1575-1580.
ABSTRACT | FULL TEXT  

Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease
Remky and Elsner
Br J Ophthalmol 2005;89:464-469.
ABSTRACT | FULL TEXT  

Reduced Foveolar Choroidal Blood Flow in Eyes with Increasing AMD Severity
Grunwald et al.
IOVS 2005;46:1033-1038.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1597-1611.
ABSTRACT | FULL TEXT  

Prospective Study of Intake of Fruits, Vegetables, Vitamins, and Carotenoids and Risk of Age-Related Maculopathy
Cho et al.
Arch Ophthalmol 2004;122:883-892.
ABSTRACT | FULL TEXT  

In Vivo Evaluation of Retinal Injury After Transient Ischemia in Hypertensive Rats
Hirose et al.
Hypertension 2004;43:1098-1102.
ABSTRACT | FULL TEXT  

Extremely Discordant Sib-Pair Study Design to Determine Risk Factors for Neovascular Age-Related Macular Degeneration
DeAngelis et al.
Arch Ophthalmol 2004;122:575-580.
ABSTRACT | FULL TEXT  

Blood Pressure, Atherosclerosis, and the Incidence of Age-Related Maculopathy: The Rotterdam Study
van Leeuwen et al.
IOVS 2003;44:3771-3777.
ABSTRACT | FULL TEXT  

Progression of Age-Related Macular Degeneration: Association With Body Mass Index, Waist Circumference, and Waist-Hip Ratio
Seddon et al.
Arch Ophthalmol 2003;121:785-792.
ABSTRACT | FULL TEXT  

Age related macular degeneration
Chopdar et al.
BMJ 2003;326:485-488.
FULL TEXT  

CNV subtype in first eyes predicts severity of ARM in fellow eyes
Abugreen et al.
Br J Ophthalmol 2003;87:307-311.
ABSTRACT | FULL TEXT  

Ten-Year Incidence of Age-related Maculopathy and Smoking and Drinking: The Beaver Dam Eye Study
Klein et al.
Am J Epidemiol 2002;156:589-598.
ABSTRACT | FULL TEXT  

Clinicopathologic Correlation of Idiopathic Polypoidal Choroidal Vasculopathy
Rosa et al.
Arch Ophthalmol 2002;120:502-508.
FULL TEXT  

Phenotypic Variation of Retinal Pigment Epithelium in Age-Related Macular Degeneration
Guidry et al.
IOVS 2002;43:267-273.
ABSTRACT | FULL TEXT  

Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration
Chen et al.
Br J Ophthalmol 2001;85:1411-1415.
ABSTRACT | FULL TEXT  

Short wavelength automated perimetry in age related maculopathy
Remky et al.
Br J Ophthalmol 2001;85:1432-1436.
ABSTRACT | FULL TEXT  

Laser Burn Intensity and the Risk for Choroidal Neovascularization in the CNVPT Fellow Eye Study
Kaiser et al.
Arch Ophthalmol 2001;119:826-832.
ABSTRACT | FULL TEXT  

Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy
SOUBRANE and BRESSLER
Br J Ophthalmol 2001;85:483-495.
FULL TEXT  

Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor--2: Potential Mechanisms for Exacerbation of Diabetic Retinopathy by Hypertension
Suzuma et al.
Diabetes 2001;50:444-454.
ABSTRACT | FULL TEXT  

Extracts from "Clinical Evidence": Age related macular degeneration
Arnold and Sarks
BMJ 2000;321:741-744.
FULL TEXT  

The second eye of Japanese patients with unilateral exudative age related macular degeneration
Uyama et al.
Br J Ophthalmol 2000;84:1018-1023.
ABSTRACT | FULL TEXT  

Prospective Study of Alcohol Consumption and the Risk of Age-Related Macular Degeneration
Cho et al.
Arch Ophthalmol 2000;118:681-688.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
Fine et al.
NEJM 2000;342:483-492.
FULL TEXT  

Photodynamic Therapy With Verteporfin Is Effective for Selected Patients With Neovascular Age-related Macular Degeneration
Fine
Arch Ophthalmol 1999;117:1400-1402.
FULL TEXT  

Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications
Frennesson and Nilsson
Br J Ophthalmol 1998;82:1169-1174.
ABSTRACT | FULL TEXT  

A Model of the Incidence and Consequences of Choroidal Neovascularization Secondary to Age-related Macular Degeneration: Comparative Effects of Current Treatment and Potential Prophylaxis on Visual Outcomes in High-Risk Patients
Lanchoney et al.
Arch Ophthalmol 1998;116:1045-1052.
ABSTRACT | FULL TEXT  

Stretch-induced Retinal Vascular Endothelial Growth Factor Expression Is Mediated by Phosphatidylinositol 3-Kinase and Protein Kinase C (PKC)-zeta but Not by Stretch-induced ERK1/2, Akt, Ras, or Classical/Novel PKC Pathways
Suzuma et al.
J. Biol. Chem. 2002;277:1047-1057.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.